Cekiç Osman, Bardak Yavuz, Tiğ Sahin U, Demirkol Aykut, Ekim Mustafa M, Altintaş Onem, Yeşildağ Ahmet, Oyar Orhan
Department of Ophthalmology, Süleyman Demirel University Medical School, Isparta, Turkey.
Int Ophthalmol. 2007 Oct;27(5):313-9. doi: 10.1007/s10792-007-9080-7. Epub 2007 May 16.
To assess ocular hemodynamic response to intravitreal triamcinolone in patients with macular edema due to diabetes or retinal vein occlusion.
Forty-three patients that were injected by intravitreal triamcinolone acetonide (0.1 cc 4 mg) for unilateral macular edema due to diabetes mellitus (n = 17) and occlusion of retinal vein (n = 26) underwent ocular hemodynamic evaluation by color Doppler imaging (CDI) before and one, two and three months after injection. Non-injected fellow eyes as well as 16 healthy volunteers were also evaluated.
In patients with diabetic macular edema, there was no hemodynamic difference between eyes to be injected and non-injected at baseline (P > 0.23). Compared to controls, a significant difference existed in the ophthalmic artery resistant index (P = 0.001) and end-diastolic velocity (P < 0.001) in diabetics. At one month, compared to fellow eyes, change in end diastolic velocity from baseline in treated eyes was significantly decreased in posterior ciliary arteries (0.68 +/- 0.34 cm/s [mean +/- SEM] vs. -1.04 +/- 0.81 cm/s, P = 0.012). Throughout the study period, no significant alteration from baseline in the resistant index of any artery was noted in treated diabetic eyes (P > 0.05). In eyes with retinal vein occlusion, baseline CDI evaluation demonstrated reduced posterior ciliary arteries systolic flow velocity compared to fellow and control eyes (13.24 +/- 1.04 cm/s, 16.37 +/- 0.76 cm/s and 14.33 +/- 1.41 cm/s, respectively, P = 0.007). Increased peak systolic velocity in the posterior ciliary arteries at one week (P = 0.02), one month (P = 0.005) and two months (P = 0.04), and increase in central retinal artery resistant index at one month was noted (P = 0.05).
Intravitreal triamcinolone temporarily changed central retinal artery blood flow and posterior ciliary arteries' peak systolic blood velocity in eyes with retinal vein occlusion whilst no response of blood flow to triamcinolone injection but only transiently altered end diastolic blood velocity in posterior ciliary arteries was observed in diabetic eyes.
评估玻璃体内注射曲安奈德对糖尿病或视网膜静脉阻塞所致黄斑水肿患者眼血流动力学的影响。
43例因糖尿病(n = 17)和视网膜静脉阻塞(n = 26)导致单侧黄斑水肿而接受玻璃体内注射曲安奈德丙酮化物(0.1 cc,4 mg)的患者,在注射前以及注射后1个月、2个月和3个月接受彩色多普勒成像(CDI)眼血流动力学评估。未注射的对侧眼以及16名健康志愿者也接受了评估。
在糖尿病性黄斑水肿患者中,注射眼与未注射眼在基线时血流动力学无差异(P > 0.23)。与对照组相比,糖尿病患者的眼动脉阻力指数(P = 0.001)和舒张末期血流速度(P < 0.001)存在显著差异。在1个月时,与对侧眼相比,治疗眼睫状后动脉舒张末期血流速度较基线的变化显著降低(0.68±0.34 cm/s[平均值±标准误]对-1.04±0.81 cm/s,P = 0.012)。在整个研究期间,治疗的糖尿病眼任何动脉的阻力指数与基线相比均无显著变化(P > 0.05)。在视网膜静脉阻塞患者中,基线CDI评估显示,与对侧眼和对照眼相比,睫状后动脉收缩期血流速度降低(分别为13.24±1.04 cm/s、16.37±0.76 cm/s和14.33±1.41 cm/s,P = 0.007)。在1周(P = 0.02)、1个月(P = 0.005)和2个月(P = 0.04)时,睫状后动脉收缩期峰值血流速度增加,且在1个月时视网膜中央动脉阻力指数增加(P = 0.05)。
玻璃体内注射曲安奈德可使视网膜静脉阻塞患者的视网膜中央动脉血流和睫状后动脉收缩期峰值血流速度暂时改变,而糖尿病患者注射曲安奈德后血流无反应,但仅使睫状后动脉舒张末期血流速度暂时改变。